FRENZ

FRENZ, developed by Earable Neuroscience, is a wearable brainband that uses artificial intelligence to monitor brain signals (EEG), eye motion (EOG), and facial micro-muscle movements (EMG) in real time, delivering personalized Cognitive Behavioral Therapy for Insomnia (CBT-i) audio content through integrated bone-conduction speakers. The device measures brain biometrics every second, adapting its intelligent playlist to help users fall asleep faster, boost deep sleep through precisely timed pink noise stimulation, and wake up refreshed at optimal sleep cycles. Clinically proven with studies published in Nature Scientific Reports, FRENZ holds over 15 patents and patent-pending breakthroughs in its compact, sleek design compatible with all adult head sizes and sleep positions. The technology differentiates itself through its non-invasive, drug-free approach to sleep therapy, targeting individuals with serious insomnia and racing thoughts at bedtime. The device is priced at $680 and is available for shipping within the US, compatible with iOS devices. Founded in 2018 and headquartered in Boulder, Colorado, FRENZ has raised $6.8M in seed funding from investors including Samsung Venture Investment, Founders Fund, Smile Gate Investment, 500 Global, and Ascend Vietnam Ventures. The company has received three CES Innovation Awards.